Gador, Jhon Laurence B.

HRN: 22-24-57  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2023
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
07/04/2023
07/11/2023
PO
3ml
BID
PCAP-C; Impetigo
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: